We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
87 hedge funds and large institutions have $461M invested in Iovance Biotherapeutics in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
173% more call options, than puts
Call options by funds: $942K | Put options by funds: $345K
38% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 24
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
7% more capital invested
Capital invested by funds: $429M → $461M (+$32M)
2% more funds holding
Funds holding: 85 → 87 (+2)
2.27% more ownership
Funds ownership: 77.09% → 79.36% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
87
Holders Change
+2
Holders Change %
+2.35%
% of All Funds
1.97%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
33
Reduced
24
Closed
12
Calls
$942K
Puts
$345K
Net Calls
+$597K
Net Calls Change
+$673K
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$8.45M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$8.2M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$8.16M |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.19M |
| 5 |
QF
QVT Financial
New York
|
+$3.72M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$11.5M |
| 2 |
O
OrbiMed
New York
|
-$7.04M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.24M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$4.31M |
| 5 |
JP Morgan Chase
New York
|
-$4.14M |
